Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

iShares S&P India Nifty 50 Index Fund (INDY), Ishares Msci Turkey Inv Market Index Fd (TUR): Are Emerging Markets Cheap?

Page 1 of 2

Due to a confluence of factors, including fears of a Chinese slowdown, global central banks putting the brakes on economic stimulus, and renewed geopolitical concerns, stock indexes in the emerging markets have declined notably in recent weeks.

iShares Silver Trust (ETF) (NYSEMKT:SLV)

Many global bourses now trade for compelling valuations, especially when compared to the domestic S&P 500 index. Of course, a heightened level of risk is usually associated with markets outside the United States.So what’s an investor to make of the emerging markets?

Turbulence across the globe
Stock markets in several countries, including India, Turkey, Thailand, and China are on a significant downtrend.

This has resulted in some cheap valuations worldwide, and investors can easily take advantage with certain exchange-traded funds, or ETFs.

Specifically, iShares offers investors exposure to India, Turkey, Thailand, and China through the iShares S&P India Nifty 50 Index Fund (NASDAQ:INDY), Ishares Msci Turkey Inv Market Index Fd (NYSEMKT:TUR), iShares MSCI Thailand Inv Mrkt Index Fd (NYSEMKT:THD), and iShares FTSE/Xinhua China 25 Index (ETF) (NYSEMKT:FXI).

Every one of these ETFs has suffered double-digit declines since the beginning of the year. That’s a striking contrast to the double-digit gains enjoyed by the S&P 500 so far this year.

Due to these declines, valuations are really getting interesting. Price-to-earnings multiples on these ETFs look very attractive. The Nifty Fifty India fund has a P/E of 13, while the Thailand and Turkey funds are valued at 11 times earnings. The China Large Cap fund is even more alluring, exchanging hands at just nine times earnings.

These multiples are especially attractive when you consider that the S&P 500 trades for a trailing earnings multiple in the high teens.

It’s easy for investors to be scared off by the fact that most international markets are down 10% or more to start the year, but that would be extremely short-term thinking. It wasn’t too long ago that emerging-market stocks were the hot new investing idea due to their strong economic-growth prospects.

Investors would be wise to remember that each of these funds outperformed the S&P 500 Index in 2012. It’s no big surprise, therefore, that the S&P has fared better over the past several weeks. At the same time, the catalysts for emerging-market outperformance are still there — namely, outsized economic growth from millions of new entrants into the middle class.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!